Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2004
10/20/2004EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists
10/20/2004EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004EP1467966A2 Water-soluble dithioesters and method for polymerization thereof
10/20/2004EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
10/20/2004EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
10/20/2004EP1467727A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
10/20/2004EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis
10/20/2004EP1443045A9 Carbanilide used as pesticide
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004EP1263725B1 Novel compounds
10/20/2004EP1246619B1 Urotensin-ii receptor antagonists
10/20/2004EP1230236B1 Compound with growth hormone releasing properties
10/20/2004EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004EP1157005B1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2004EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
10/20/2004EP1109551A4 4-amino-3-mercapto-1,2,4-triazoles
10/20/2004EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/20/2004EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004EP0850062B1 Use of halofuginone for the preparation of a medicament for attenuating neovascularization and for treating human malignant tumours
10/20/2004CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004CN1538966A 喹唑啉酮衍生物 Quinazolinone derivatives
10/20/2004CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them
10/20/2004CN1538956A Spiro compounds
10/20/2004CN1538848A Novel Benzo-fused heterocycles
10/20/2004CN1538845A Phenyl derivatives as factor Xa inhibitors
10/20/2004CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use
10/20/2004CN1538836A Substituted amine derivatives and method of use
10/20/2004CN1171887C Respiratory syncytial virus replication inhibitors
10/20/2004CN1171886C Process for producing carbostyril derivative
10/20/2004CN1171885C Crystal of benzimidazole derivatives and their production
10/20/2004CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
10/20/2004CN1171870C Inhibitors of cysteine protease
10/20/2004CN1171582C Oral pharmaceutical extended release dosage form
10/19/2004US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/19/2004US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004US6806286 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/19/2004US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists
10/19/2004US6806277 Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them
10/19/2004US6806276 2-oxoquinoline compounds and pharmaceutical uses thereof
10/19/2004US6806275 Arylpiperidine derivatives and use thereof
10/19/2004US6806274 Quinazoline derivatives
10/19/2004US6806230 Pyrimidine derivatives and herbicides containing them
10/19/2004US6806229 Herbicidally active pyridine sulfonyl urea derivatives
10/19/2004CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/19/2004CA2296901C Piperidine derivates having anxiolytic effect
10/19/2004CA2155796C 2,3-dihydro-1h-isoindole derivatives, a process for their preparation and their use as serotonin reuptake inhibitors
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
10/14/2004WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
10/14/2004WO2004087689A1 Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
10/14/2004WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions
10/14/2004WO2004087679A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
10/14/2004WO2004087677A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
10/14/2004WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087659A1 Chemical compounds
10/14/2004WO2004087653A2 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
10/14/2004WO2004087647A2 4-substituted quinolein derivatives with antimicrobial activity
10/14/2004WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
10/14/2004WO2004087142A1 Quinoline-2-one-derivatives for the treatment of airways diseases
10/14/2004WO2004087137A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/14/2004WO2004087133A1 Crystalline n-formyl hydroxylamine compounds
10/14/2004WO2004087075A2 Compositions and methods for treating cancer
10/14/2004WO2004087074A2 Process for making substituted pyrazoles
10/14/2004WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
10/14/2004WO2004087053A2 Dipeptidyl peptidase inhibitors
10/14/2004WO2004087051A2 Ophthalmic compositions for treating ocular hypertension
10/14/2004WO2004087050A2 Mitotic kinesin inhibitors
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004078116A3 P38 inhibitors and methods of use thereof
10/14/2004WO2004058700A3 Mitotic kinesin inhibitors
10/14/2004WO2004050636A3 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/14/2004WO2004037176A3 Quinazolinones and derivatives thereof as factor xa inhibitors
10/14/2004US20040204586 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/14/2004US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex
10/14/2004US20040204455 For therapy of hypertension, and congestive heart failure
10/14/2004US20040204454 Lactam-containing cyclic diamines and derivatives as factor Xa inhibitors
10/14/2004US20040204453 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders
10/14/2004US20040204452 to decompose peroxynitrite anion into harmless nitrate or nitrite endproducts which prevents the free radical-mediated cell damage; cytoprotective; Alzheimer's disease; 3,5-dimethylisoxazole-4-sulfonic acid 4-pyrrolidin-1-ylphenylamide
10/14/2004US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia
10/14/2004US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders
10/14/2004US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004US20040204436 Imidazonaphthyridines
10/14/2004US20040204426 4-Imidazolin-2-one compounds
10/14/2004US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
10/14/2004US20040204421 Certain 1,3-disubstituted isoquinoline derivatives
10/14/2004US20040204417 For therapy of cancer
10/14/2004US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004US20040204410 Such as 1-(4,5-Bis-(4-chloro-phenyl)-2-(2,4-dimethoxy-phenyl)-4,5-dihydro-imidazol-1-yl)-2-methyl-propan-1-one which inhibits the interaction of MDM2 protein with p53-like peptide; antiproliferative agents
10/14/2004US20040204407 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
10/14/2004US20040204406 Pyrazole-derivatives as factor Xa inhibitors
10/14/2004US20040204402 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
10/14/2004US20040204397 Calcitonin gene related peptide receptor antagonists
10/14/2004US20040204386 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell)
10/14/2004US20040204369 Novel amide derivatives
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders